Evaluating Radiation-Related Risk Factors for Pneumonitis in Patients with Stage III NSCLC Receiving Durvalumab after Definitive Chemoradiation
| Autor: | Dong, L., Mo, X., Patel, S., Haglund, K.E., Williams, T.M., Brownstein, J.M., Owen, D., Welliver, M.X. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e370-e371 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|